Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells

Anticancer Research

Volumn 32, Issue 11, 2012, Pages 4833-4842

  Wu, King Chuen ^a   Yang, Su Tso ^b,c   Hsia, Te Chun ^b   Yang, Jai Sing ^c   Chiou, Shang Ming ^b   Lu, Chi Cheng ^d   Wu, Rick Sai Chuen ^b   Chung, Jing Gung ^c,e  

^a I SHOU UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

Author keywords

Human lung adenocarcinoma epithelial a549 cells; Invasion; Migration; MMP 2; P38 mapk; Propofol

Indexed keywords

GELATINASE A; GELATINASE B; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MATRILYSIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROPOFOL; STRESS ACTIVATED PROTEIN KINASE 1; SYNAPTOPHYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CARCINOMA CELL; CELL ADHESION; CELL ASSAY; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ADENOCARCINOMA; METASTASIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WOUND HEALING; ZYMOGRAPHY;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DOWN-REGULATION; ENZYME ACTIVATION; EPITHELIAL CELLS; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROPOFOL; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84872650420     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Hodkinson PS and Sethi T: Advances in the prevention and treatment of lung cancer. J R Coll Physicians Edinb 41: 142-149, 2011.
2. Soria JC, Kim ES, Fayette J, Lantuejoul S, Deutsch E and Hong WK: Chemoprevention of lung cancer. Lancet Oncol 4: 659-669, 2003.
3. Schiller JH: Lung cancer: therapeutic modalities and cytoprotection. Lung 176: 145-164, 1998.
4. Fonseca FL, Azzalis LA, Feder D, Nogoceke E, Junqueira VB, Valenti VE and de Abreu LC: Adhesion molecules affected by treatment of lung cancer cells with epidermal growth factor. Lung 189: 383-389, 2011.
5. Blackhall F, Ranson M and Thatcher N: Where next for gefitinib in patients with lung cancer? Lancet Oncol 7: 499-507, 2006.
6. Osmak M, Niksic D, Brozovic A, Ristov AA, Vrhovec I and Skrk J: Drug resistant tumor cells have increased levels of tumor markers for invasion and metastasis. Anticancer Res 19: 3193-3197, 1999.
7. Akedo H, Shinkai K, Mukai M and Komatsu K: Potentiation and inhibition of tumor cell invasion by host cells and mediators. Invasion Metastasis 9: 134-148, 1989.
8. Mehlen P and Puisieux A: Metastasis: A question of life or death. Nat Rev Cancer 6: 449-458, 2006.
9. Forest V, Campos L, Vergnon JM, Cornillon J and Guyotat D: Characterization of the focal adhesion complex in human non-small cell lung cancer cell lines. Anticancer Res 25: 4135-4139, 2005.
10. Deegan RJ: Propofol: a review of the pharmacology and applications of an intravenous anesthetic agent. Am J Med Sci 304: 45-49, 1992.
11. Irifune M, Takarada T, Shimizu Y, Endo C, Katayama S, Dohi T and Kawahara M: Propofol-induced anesthesia in mice is mediated by gamma-aminobutyric acid-A and excitatory amino acid receptors. Anesth Analg 97: 424-429, 2003.
12. Kozinn J, Mao L, Arora A, Yang L, Fibuch EE and Wang JQ: Inhibition of glutamatergic activation of extracellular signal-regulated protein kinases in hippocampal neurons by the intravenous anesthetic propofol. Anesthesiology 105: 1182-1191, 2006.
13. Trapani G, Altomare C, Liso G, Sanna E and Biggio G: Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery. Curr Med Chem 7: 249-271, 2000.
14. Wang B, Luo T, Chen D and Ansley DM: Propofol reduces apoptosis and up-regulates endothelial nitric oxide synthase protein expression in hydrogen peroxide-stimulated human umbilical vein endothelial cells. Anesth Analg 105: 1027-1033, 2007.
15. Xu JJ and Wang YL: Propofol attenuation of hydrogen peroxide-mediated oxidative stress and apoptosis in cultured cardiomyocytes involves haeme oxygenase-1. Eur J Anaesthesiol 25: 395-402, 2008.
16. Chen J, Gu Y, Shao Z, Luo J and Tan Z: Propofol protects against hydrogen peroxide-induced oxidative stress and cell dysfunction in human umbilical vein endothelial cells. Mol Cell Biochem 339: 43-54, 2010.
17. Wang B, Shravah J, Luo H, Raedschelders K, Chen DD and Ansley DM: Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 upregulation. Biochem Biophys Res Commun 389: 105-111, 2009.
18. Kobayashi K, Yoshino F, Takahashi SS, Todoki K, Maehata Y, Komatsu T, Yoshida K and Lee MC: Direct assessments of the antioxidant effects of propofol medium chain triglyceride/long chain triglyceride on the brain of stroke-prone spontaneously hypertensive rats using electron spin resonance spectroscopy. Anesthesiology 109: 426-435, 2008.
19. Gulcin I, Alici HA and Cesur M: Determination of in vitro antioxidant and radical scavenging activities of propofol. Chem Pharm Bull (Tokyo) 53: 281-285, 2005.
20. Kahraman S, Kilinc K, Dal D and Erdem K: Propofol attenuates formation of lipid peroxides in tourniquet-induced ischaemia-reperfusion injury. Br J Anaesth 78: 279-281, 1997.
21. Peng Z, Luo M, Ye S, Critchley LA, Joynt GM, Ho AM and Yao S: Antioxidative and anti-endotoxin effects of propofol on endothelial cells. Chin Med J (Engl) 116: 731-735, 2003.
22. Eriksson O: Effects of the general anaesthetic Propofol on the Ca 2(+)-induced permeabilization of rat liver mitochondria. FEBS Lett 279: 45-48, 1991.
23. Fredriksson A, Ponten E, Gordh T and Eriksson P: Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits. Anesthesiology 107: 427-436, 2007.
24. Feng CS, Ma HC, Yue Y, Zhang YQ and Qu XD: Effect of propofol on the activation of nuclear factor-kappa B and expression of inflammatory cytokines in cerebral cortex during transient focal cerebral ischemia-reperfusion: experiment with rats. Zhonghua Yi Xue Za Zhi 84: 2110-2114, 2004.
25. Sanchez-Conde P, Rodriguez-Lopez JM, Nicolas JL, Lozano FS, Garcia-Criado FJ, Cascajo C, Gonzalez-Sarmiento R and Muriel C: The comparative abilities of propofol and sevoflurane to modulate inflammation and oxidative stress in the kidney after aortic cross-clamping. Anesth Analg 106: 371-378, 2008.
26. Nakahata K, Kinoshita H, Azma T, Matsuda N, Hama-Tomioka K, Haba M and Hatano Y: Propofol restores brain microvascular function impaired by high glucose via the decrease in oxidative stress. Anesthesiology 108: 269-275, 2008.
27. Liu KX, Rinne T, He W, Wang F and Xia Z: Propofol attenuates intestinal mucosa injury induced by intestinal ischemia-reperfusion in the rat. Can J Anaesth 54: 366-374, 2007.
28. Tsuchiya M, Asada A, Arita K, Utsumi T, Yoshida T, Sato EF, Utsumi K and Inoue M: Induction and mechanism of apoptotic cell death by propofol in HL-60 cells. Acta Anaesthesiol Scand 46: 1068-1074, 2002.
29. Wu RS, Liu KC, Tang NY, Chung HK, Ip SW, Yang JS and Chung JG: cDNA microarray analysis of the gene expression of murine leukemia RAW 264.7 cells after exposure to propofol. Environ Toxicol, 2011, in press.
30. Mammoto T, Mukai M, Mammoto A, Yamanaka Y, Hayashi Y, Mashimo T, Kishi Y and Nakamura H: Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Lett 184: 165-170, 2002.
31. Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL, Lin JP, Ma YS, Wu CC and Chung JG: Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor (VEGF). Cancer Lett 285: 127-133, 2009.
32. Chiang JH, Yang JS, Ma CY, Yang MD, Huang HY, Hsia TC, Kuo HM, Wu PP, Lee TH and Chung JG: Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and BAX-triggered pathways. Chem Res Toxicol 24: 20-29, 2011.
33. Lu CC, Yang JS, Huang AC, Hsia TC, Chou ST, Kuo CL, Lu HF, Lee TH, Wood WG and Chung JG: Chrysophanol induces necrosis through the production of ROS and alteration of ATP levels in J5 human liver cancer cells. Mol Nutr Food Res 54: 967-976, 2010.
34. Chen PN, Chu SC, Chiou HL, Kuo WH, Chiang CL and Hsieh YS: Mulberry anthocyanins, cyanidin 3-rutinoside and cyanidin 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line. Cancer Lett 235: 248-259, 2006.
35. Liu KC, Huang AC, Wu PP, Lin HY, Chueh FS, Yang JS, Lu CC, Chiang JH, Meng M and Chung JG: Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways. Oncol Rep 26: 177-184, 2011.
36. Ho YT, Yang JS, Li TC, Lin JJ, Lin JG, Lai KC, Ma CY, Wood WG and Chung JG: Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9. Cancer Lett 279: 155-162, 2009.
37. Ma CY, Ji WT, Chueh FS, Yang JS, Chen PY, Yu CC and Chung JG: Butein inhibits the migration and invasion of SK-HEP-1 human hepatocarcinoma cells through suppressing the ERK, JNK, p38, and uPA signaling multiple pathways. J Agric Food Chem 59: 9032-9038, 2011.
38. Chen YY, Chiang SY, Lin JG, Ma YS, Liao CL, Weng SW, Lai TY and Chung JG: Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9. Int J Oncol 36: 1113-1120, 2010.
39. Lo C, Lai TY, Yang JS, Yang JH, Ma YS, Weng SW, Lin HY, Chen HY, Lin JG and Chung JG: Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras. Melanoma Res 21: 267-273, 2011.
40. Mozaffarieh M, Konieczka K, Hauenstein D, Schoetzau A and Flammer J: Half a pack of cigarettes a day more than doubles DNA breaks in circulating leukocytes. Tob Induc Dis 8: 14, 2010.
41. Heid CA, Stevens J, Livak KJ and Williams PM: Real-time quantitative PCR. Genome Res 6: 986-994, 1996.
42. Zhang L, Shi J, Feng J, Klocker H, Lee C and Zhang J: Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer. Prostate Cancer Prostatic Dis 7: 327-332, 2004.
43. Guruvayoorappan C and Kuttan G: Amentoflavone inhibits experimental tumor metastasis through a regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, NM23 and cytokines in lung tissues of C57BL/6 mice. Immunopharmacol Immunotoxicol 30: 711-727, 2008.
44. Coussens LM and Werb Z: Matrix metalloproteinases and the development of cancer. Chem Biol 3: 895-904, 1996.
45. Waas ET, Wobbes T, Lomme RM, DeGroot J, Ruers T and Hendriks T: Matrix metalloproteinase-2 and -9 activity in patients with colorectal cancer liver metastasis. Br J Surg 90: 1556-1564, 2003.
46. Tsuji T, Kawada Y, Kai-Murozono M, Komatsu S, Han SA, Takeuchi K, Mizushima H, Miyazaki K and Irimura T: Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3). Clin Exp Metastasis 19: 127-134, 2002.
47. Rao JS: Molecular mechanisms of glioma invasiveness: The role of proteases. Nat Rev Cancer 3: 489-501, 2003.
48. Fidler IJ: The organ microenvironment and cancer metastasis. Differentiation 70: 498-505, 2002.
49. Fidler IJ, Kim SJ and Langley RR: The role of the organ microenvironment in the biology and therapy of cancer metastasis. J Cell Biochem 101: 927-936, 2007.
50. Chakraborti S, Mandal M, Das S, Mandal A and Chakraborti T: Regulation of matrix metalloproteinases: An overview. Mol Cell Biochem 253: 269-285, 2003.
51. Stetler-Stevenson WG, Hewitt R and Corcoran M: Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic. Semin Cancer Biol 7: 147-154, 1996.
52. Sawicki G, Radomski MW, Winkler-Lowen B, Krzymien A and Guilbert LJ: Polarized release of matrix metalloproteinase-2 and -9 from cultured human placental syncytiotrophoblasts. Biol Reprod 63: 1390-1395, 2000.
53. Kondapaka SB, Fridman R and Reddy KB: Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int J Cancer 70: 722-726, 1997.